|Daily Range||$5.51 - $5.66|
|52-Week Range||$3.85 - $8.14|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||187,878|
|Current FY EPS||-$0.06|
How do you think SVA
will perform against the market?
Top SVA Bull/Bear Pitches
zzlangerhans (< 20)
Submitted July 23, 2013
Sinovac has been grinding out growth in YoY vaccine revenues while limiting their cash burn and achieving acceptance of their regulatory application for the EV71 hand-foot-mouth disease vaccine in Chi … More
TMFBreakerBrian (< 20)
Submitted June 10, 2008
Any company garnering a positive rating from Dutton Associates should set off all sorts of warning bells to investors.
Sinovac Biotech Ltd. (SVA) Description
A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Website: http://www.sinovac.com/